论文部分内容阅读
目的:分析宫腹腔镜联合辅助生殖技术治疗输卵管性不孕患者的临床疗效和安全性。方法:入选此研究中的94例研究对象均为我院于2015年2月-2016年4月期间收治的输卵管性不孕患者,依据治疗方法的不同平均分为观察和对照两组,两组患者均采用宫腹腔镜进行治疗,观察组与此同时联合辅助生殖技术方法,对两组患者的临床疗效进行比对。结果:观察组和对照组患者经治疗后,输卵管再通率和并发症发生率经对比后未形成统计学意义,而1年内妊娠率以及2年内妊娠率经对比统计学意义形成。结论:将宫腹腔镜联合辅助生殖技术方法应用于输卵管性不孕患者的治疗中,安全性良好,效果显著。
Objective: To analyze the clinical efficacy and safety of hysteroscopy combined with assisted reproductive technology in the treatment of tubal infertility. Methods: Ninety-four subjects enrolled in this study were all oviduct infertility patients who were treated in our hospital from February 2015 to April 2016. The patients were divided into observation and control groups according to the average of the treatment methods. Two groups Patients were treated with laparoscopic hysteroscopy, the observation group at the same time combined with assisted reproductive technology methods, the clinical efficacy of the two groups were compared. Results: After treatment, the recanalization rate and complication rate of tubal in observation group and control group did not reach statistical significance after the treatment, but the pregnancy rate in one year and the pregnancy rate in two years were statistically significant. Conclusion: The method of hysteroscopy combined with assisted reproductive technology in the treatment of tubal infertility patients with good safety, the effect is significant.